Disulfiram: A novel repurposed drug for cancer therapy.

Zeng M, Wu B, Wei W, Jiang Z, Li P, Quan Y, Hu X

DOI: 10.1097/cm9.0000000000002909
Published: 2024 Jun 20
Container: Chinese medical journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/cm9.0000000000002909,
  title = {Disulfiram: A novel repurposed drug for cancer therapy.},
  author = {Zeng M and Wu B and Wei W and Jiang Z and Li P and Quan Y and Hu X},
  year = {2024},
  journal = {Chinese medical journal},
  doi = {10.1097/cm9.0000000000002909},
  url = {https://doi.org/10.1097/cm9.0000000000002909}
}

RIS

TY  - JOUR
TI  - Disulfiram: A novel repurposed drug for cancer therapy.
AU  - Zeng M
AU  - Wu B
AU  - Wei W
AU  - Jiang Z
AU  - Li P
AU  - Quan Y
AU  - Hu X
PY  - 2024
JO  - Chinese medical journal
DO  - 10.1097/cm9.0000000000002909
UR  - https://doi.org/10.1097/cm9.0000000000002909
ER  -

APA

M, Z., B, W., W, W., Z, J., P, L., Y, Q., & X, H. (2024). Disulfiram: A novel repurposed drug for cancer therapy.. Chinese medical journal. https://doi.org/10.1097/cm9.0000000000002909

Source records

pubmed · retrieved 2026-09-26T01:37:25.370Z